1. Home
  2. GPRO vs CERS Comparison

GPRO vs CERS Comparison

Compare GPRO & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GoPro Inc.

GPRO

GoPro Inc.

HOLD

Current Price

$0.86

Market Cap

282.4M

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.17

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GPRO
CERS
Founded
2004
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
EDP Services
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
282.4M
276.0M
IPO Year
2014
1997

Fundamental Metrics

Financial Performance
Metric
GPRO
CERS
Price
$0.86
$2.17
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
3.4M
1.4M
Earning Date
03-05-2026
02-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$650,751,000.00
$199,191,000.00
Revenue This Year
N/A
$25.31
Revenue Next Year
$12.41
$9.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
13.03
52 Week Low
$0.40
$1.12
52 Week High
$3.05
$2.96

Technical Indicators

Market Signals
Indicator
GPRO
CERS
Relative Strength Index (RSI) 25.30 45.00
Support Level $0.93 $2.11
Resistance Level $1.06 $2.26
Average True Range (ATR) 0.09 0.13
MACD -0.02 -0.04
Stochastic Oscillator 5.63 27.27

Price Performance

Historical Comparison
GPRO
CERS

About GPRO GoPro Inc.

GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: